Department of Biomedical Engineering, The University of Texas at Austin, Austin, Texas 78712, USA.
Tissue Eng Part A. 2010 Nov;16(11):3285-98. doi: 10.1089/ten.TEA.2010.0166. Epub 2010 Jul 12.
Embryonic stem (ES)-cell-derived lineage-specific stem cells, for example, hematopoietic stem cells, could provide a potentially unlimited source for transplantable cells, especially for cell-based therapies. However, reproducible methods must be developed to maximize and scale-up ES cell differentiation to produce clinically relevant numbers of therapeutic cells. Bioreactor-based dynamic culture conditions are amenable to large-scale cell production, but few studies have evaluated how various bioreactor types and culture parameters influence ES cell differentiation, especially hematopoiesis. Our results indicate that cell seeding density and bioreactor speed significantly affect embryoid body formation and subsequent generation of hematopoietic stem and progenitor cells in both stirred tank (spinner flask) and rotary microgravity (Synthecon™) type bioreactors. In general, high percentages of hematopoietic stem and progenitor cells were generated in both bioreactors, especially at high cell densities. In addition, Synthecon bioreactors produced more sca-1(+) progenitors and spinner flasks generated more c-Kit(+) progenitors, demonstrating their unique differentiation profiles. cDNA microarray analysis of genes involved in pluripotency, germ layer formation, and hematopoietic differentiation showed that on day 7 of differentiation, embryoid bodies from both bioreactors consisted of all three germ layers of embryonic development. However, unique gene expression profiles were observed in the two bioreactors; for example, expression of specific hematopoietic genes were significantly more upregulated in the Synthecon cultures than in spinner flasks. We conclude that bioreactor type and culture parameters can be used to control ES cell differentiation, enhance unique progenitor cell populations, and provide means for large-scale production of transplantable therapeutic cells.
胚胎干细胞(ES)衍生的谱系特异性干细胞,例如造血干细胞,可以为移植细胞提供潜在的无限来源,特别是对于细胞为基础的治疗方法。然而,必须开发可重复的方法来最大化和扩大 ES 细胞分化,以产生临床相关数量的治疗细胞。基于生物反应器的动态培养条件适用于大规模细胞生产,但很少有研究评估各种生物反应器类型和培养参数如何影响 ES 细胞分化,特别是造血作用。我们的结果表明,细胞接种密度和生物反应器速度显著影响胚胎体的形成和随后在搅拌罐(旋转瓶)和旋转微重力(Synthecon™)型生物反应器中造血干细胞和祖细胞的生成。通常,在两种生物反应器中,尤其是在高细胞密度下,产生了更高比例的造血干细胞和祖细胞。此外,Synthecon 生物反应器产生了更多的 sca-1(+)祖细胞,而旋转瓶产生了更多的 c-Kit(+)祖细胞,证明了它们独特的分化谱。参与多能性、胚层形成和造血分化的基因的 cDNA 微阵列分析表明,在分化的第 7 天,来自两种生物反应器的胚胎体均由胚胎发育的三个胚层组成。然而,在两种生物反应器中观察到了独特的基因表达谱;例如,Synthecon 培养物中特定造血基因的表达明显高于旋转瓶。我们得出结论,生物反应器类型和培养参数可用于控制 ES 细胞分化,增强独特的祖细胞群体,并为可移植治疗细胞的大规模生产提供手段。